Cases 1 - 10 of 17
BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD et al
as 2:2021cv00573
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED and SALIX PHARMACEUTICALS, INC
Defendant:
AGILA SPECIALTIES INC, MYLAN INC, VIATRIS INC and others
Cause Of Action: 35 U.S.C. § 271
Bausch Health Ireland Limited et al v. Mylan Laboratories Ltd. et al
as 1:2021cv00611
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant:
Agila Specialties Inc., Mylan Pharmaceuticals Inc., Mylan Inc. and others
Cause Of Action: 35 U.S.C. § 1
BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD. et al
as 2:2021cv10403
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED and SALIX PHARMACEUTICALS, INC.
Defendant:
AGILA SPECIALTIES INC., MYLAN INC., MYLAN PHARMACEUTICALS INC. A VIATRIS COMPANY and others
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al
as 3:2020cv02749
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH US, LLC and others
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
VIFOR (INTERNATIONAL) AG et al v. MYLAN LABORATORIES LTD.
as 3:2020cv01647
Plaintiff:
AMERICAN REGENT, INC. and VIFOR (INTERNATIONAL) AG
Defendant:
MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
VIFOR (INTERNATIONAL) AG et al v. MYLAN LABORATORIES LTD.
as 3:2019cv13955
Plaintiff:
AMERICAN REGENT, INC. and VIFOR (INTERNATIONAL) AG
Defendant:
MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. MYLAN PHARMACEUTICALS INC. et al
as 3:2019cv08233
Plaintiff:
KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals International GmbH et al v. Fresenius Kabi USA, LLC et al
as 1:2018cv01586
Plaintiff:
Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. and Cephalon, Inc.
Defendant:
Fresenius Kabi USA, LLC and Mylan Laboratories Ltd.
Cause Of Action: 28 U.S.C. § 2201
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. MYLAN PHARMACEUTICALS INC. et al
as 3:2018cv14305
Plaintiff:
KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
ViiV Healthcare Company et al v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv01671
Plaintiff:
ViiV Healthcare Company , Shionogi & Co., Ltd. and ViiV Healthcare UK (No. 3) Limited
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
